Medical University of Lodz
umed.plTotal trials
101
Active
7
Phase 3
3
Total enrollment
31,632
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Infliximab | — | — | — | — | — | 1 | |
| Ustekinumab | — | — | — | — | — | 1 | |
| Lisdexamfetamine | — | — | — | — | — | 1 | |
| Methylphenidate | — | — | — | — | — | 1 | |
| dimethyl fumarate | — | — | — | — | — | 1 | |
| 1ml of Depo-Medrol® | — | — | — | — | — | 1 | |
| Nerve block with 4ml of 2% lidocaine | — | — | — | — | — | 1 | |
| Tropocells® PRP | — | — | — | — | — | 1 |
Next readouts
- 2026-05-01
- 2027-12-01
- 2027-12-31
- 2028-04-30
Top conditions
- Asthma16
- Depression5
- Hypertension4
- Bronchial Asthma4
- Allergic Rhinitis4
- Intubation Complication4
- Anxiety4
- Schizophrenia4
Frequently asked questions about Medical University of Lodz
- How many clinical trials does Medical University of Lodz have on ClinicalTrials.gov?
- Medical University of Lodz is listed as the lead sponsor on 101 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of Lodz's trials are in Phase 3?
- 3 of Medical University of Lodz's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does Medical University of Lodz focus on?
- Medical University of Lodz's most-studied conditions on ClinicalTrials.gov are Asthma, Depression, Hypertension, Bronchial Asthma, Allergic Rhinitis.
- When are Medical University of Lodz's next clinical trial readouts?
- Medical University of Lodz has 4 upcoming primary-completion readouts tracked here; the soonest is “Conservative Treatment in Patients With Supraspinatus Tendon Injury.”, expected around 2026-05-01.